Summary: Learn where you can get a swine flu shot, and a little bit about National Influenza Vaccination week.
Tags: Where to get a swine flu shot, National Influenze Accination Week, how are flu vaccinations developed
You can get a swine flu shot at many neighborhood locations such as grocery stores, pharmacies, doctor's office and medical clinics.
More Info: By late September, 2010, more than 103 million individual doses vaccine products designed to treat swine flu (H1N1) had been distributed in the United States as part of the federal government mandated campaign for the 2010-2011 flu season. The five flu shots recommended by the Advisory Committee on Immunization Practices (ACIP) are Fluzone, Fluvirin, Agriflu, Fluarix and Flulaval. They can be purchased at grocery stores, pharmacies, doctor's offices, medical clinics and many other neighborhood locations.
National Influenza Vaccination Week
In the wake of the outbreak of the swine flu in 2009, when a panicked U.S. population had to wait until early October of that year for the H1N1 flu shots to become available, distribution efforts were put in place early for the 2010-2011 flu season. The period of December 5 through the 11th, 2010, will be known as National Influenza Vaccination Week. The goal is to remind people how important it is to consider a second flu shot heading into the rest of the 2010-2011 flu season. Ideally, the Centers for Disease Control and associated groups would like to see those most at risk get into the habit of getting not one but two flu shots per year. One in September and another in January.
How Are Flu Vaccines Produced?
Most people who get flu shots probably do not realize the arcane way the medications are produced. In fact, at the tail end of the 2009-2010 H1N1 season, the cry went out more efficient flu shot manufacturing techniques to be developed in the future. Flu vaccines are developed inside eggs that are injected with a weakened version of the virus, a process that takes between six and nine months. As a result of the lessons learned in 2009-2010, the U.S. government in partnership with the private sector has begun looking into ways to develop the speedier production of flu vaccines.
The goal is to eventually shift to a cell-based production standard, wherein DNA of the flu vaccine is perpetually recombined and reproduced. Although the marshaling of a global response to the influenza epidemics of the 21st century has become a mostly admirable exercise, the production of the preferred treatment methods is stuck squarely in the early 20th century.